CD4 and neoplasm: Mechanistically, celecoxib inhibited the COX2 effect and suppressed PGE2 production, which in turn elevated the infiltration of CD3+, CD4+, and CD8+ T cells, as well as NK cells, resulting in the suppression of tumour growth.